中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
10期
9-10
,共2页
氟伏沙明%精神分裂症%强迫症状
氟伏沙明%精神分裂癥%彊迫癥狀
불복사명%정신분렬증%강박증상
Fluvoxamine%Schizophrenia%Obsessive-compulsive symptoms
目的:探讨氟伏沙明对精神分裂症患者伴发强迫症状的疗效。方法:精神分裂症伴强迫症状患者60例,随机分为研究组(氟伏沙明合并奥氮平组)和对照组(奥氮平组)各30例。患者于治疗前及治疗后8周末应用阳性和阴性症状量表( PANSS)、耶鲁-布朗强迫症状量表(Y-BOCS)和副反应量表(TESS)评定疗效及不良反应。结果:治疗后,研究组患者较对照组 PANSS、Y-BOCS 评分下降更显著(P<0.01),TESS评分无显著差异(P>0.05)。结论:氟伏沙明结合抗精神病药物治疗较单用抗精神病药物治疗能提高伴发强迫症状的精神分裂症患者的疗效。
目的:探討氟伏沙明對精神分裂癥患者伴髮彊迫癥狀的療效。方法:精神分裂癥伴彊迫癥狀患者60例,隨機分為研究組(氟伏沙明閤併奧氮平組)和對照組(奧氮平組)各30例。患者于治療前及治療後8週末應用暘性和陰性癥狀量錶( PANSS)、耶魯-佈朗彊迫癥狀量錶(Y-BOCS)和副反應量錶(TESS)評定療效及不良反應。結果:治療後,研究組患者較對照組 PANSS、Y-BOCS 評分下降更顯著(P<0.01),TESS評分無顯著差異(P>0.05)。結論:氟伏沙明結閤抗精神病藥物治療較單用抗精神病藥物治療能提高伴髮彊迫癥狀的精神分裂癥患者的療效。
목적:탐토불복사명대정신분렬증환자반발강박증상적료효。방법:정신분렬증반강박증상환자60례,수궤분위연구조(불복사명합병오담평조)화대조조(오담평조)각30례。환자우치료전급치료후8주말응용양성화음성증상량표( PANSS)、야로-포랑강박증상량표(Y-BOCS)화부반응량표(TESS)평정료효급불량반응。결과:치료후,연구조환자교대조조 PANSS、Y-BOCS 평분하강경현저(P<0.01),TESS평분무현저차이(P>0.05)。결론:불복사명결합항정신병약물치료교단용항정신병약물치료능제고반발강박증상적정신분렬증환자적료효。
Objective:To explore efficacy of Fluvoxamine in treatment of patients with schizophrenia combined with obsessive-compulsive symptoms. Methods:60 patients with schizophrenia combined with obsessive-compulsive symptoms were randomly divided into study group (30 cases, treated with Fluvoxamine plus olanzapine) and control group (30 cases, treated with olanzapine). The curative effect was assessed by using positive and negative symptom scale ( PANSS ) , Yale-Brown obsessive-compulsive scale (YBOCS) and adverse reactions was assessed by using treatment emergent symptom scale (TESS) at baseline and at the 8th weekend of the treatment. Results:After the treatment, the decrease of PANSS and YBOCS scores in study group was more obvious than that in control group (P<0. 01), while score of TESS was insignificant between the two groups(P>0. 05). Conclusions: Fluvoxamine com-bined with antipsychotic drugs has better effects than single antipsychotic drugs for the patients with schizophrenia combined with ob-sessive-compulsive symptoms.